Maria Paz Villegas-Perez

11PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous systemOptical technologyAnimal neurobiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 11, 2026
Minocycline and bone marrow-derived mononuclear cells as potential therapeutics for hereditary retinal degenerations.

Alba Videla-Ristol, Ana Martínez-Vacas, David García-Bernal

|Feb 13, 2026
Systemic Inflammation Aggravates Retinal Ganglion Cell Vulnerability to Optic Nerve Trauma in Adult Rats.

Giuseppe Rovere, Yolanda Caja-Matas, Beatriz Vidal-Villegas

|May 15, 2023
Effects of the periocular botulinum toxin on the ocular surface and anterior chamber: a prospective study in patients with hemifacial spasm and blepharospasm.

María Dolores Romero-Caballero, Juan Antonio Miralles de Imperial-Ollero, Elena Sarabia-Marín

|Jan 11, 2022
Glial Cell Activation and Oxidative Stress in Retinal Degeneration Induced by β-Alanine Caused Taurine Depletion and Light Exposure.

Ana Martínez-Vacas, Johnny Di Pierdomenico, Francisco J Valiente-Soriano

|Nov 27, 2021
Animal Models of LED-Induced Phototoxicity. Short- and Long-Term In Vivo and Ex Vivo Retinal Alterations.

Juan A Miralles de Imperial-Ollero, Alejandro Gallego-Ortega, Arturo Ortín-Martínez

|Nov 13, 2021
7,8-Dihydroxiflavone Maintains Retinal Functionality and Protects Various Types of RGCs in Adult Rats with Optic Nerve Transection.

Alejandro Gallego-Ortega, Beatriz Vidal-Villegas, María Norte-Muñoz

Pageof 2